Products

What will AGI do for Alprenolol benzoate?

This classification denotes a beta-adrenergic blocking agent C15H23NO2.C7H6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T3H696761C, chemically known as benzoic acid, compd. with 1-((1-methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-2-propanol (1:1), but more generally known as alprenolol benzoate, which bears US NIH Compound Identifier 9951320. European Medicines Agency schedules Alprenolol benzoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00377MIG. Most nations, for tariff and trade purposes, schedule alprenolol benzoate under HS 29221980 and SITC 51461. As of Q4 2014, ALPRENOLOL BENZOATE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)NCC(COC1CCCCC1CC=C)O.C1CCC(CC1)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Alprenolol benzoate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alprenolol benzoate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alprenolol benzoate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alprenolol benzoate connects

measured by

  • Assay Puritymodel
  • Compound Puritymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Residual Solventmodel
  • Salt Stoichiometrymodel